These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9200012)

  • 21. Resorptive state and cell size influence intracellular pH regulation in rabbit osteoclasts cultured on collagen-hydroxyapatite films.
    Lees RL; Sabharwal VK; Heersche JN
    Bone; 2001 Feb; 28(2):187-94. PubMed ID: 11182377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel inhibitor of vacuolar ATPase, FR167356, which can discriminate between osteoclast vacuolar ATPase and lysosomal vacuolar ATPase.
    Niikura K; Takano M; Sawada M
    Br J Pharmacol; 2004 Jun; 142(3):558-66. PubMed ID: 15148249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of osteoclasts by interleukin-1: divergent responsiveness in osteoclasts formed in vivo and in vitro.
    Fox SW; Fuller K; Chambers TJ
    J Cell Physiol; 2000 Sep; 184(3):334-40. PubMed ID: 10911364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pharmacological assessment of the mammalian osteoclast vacuolar H(+)-ATPase.
    Hall TJ; Schaueblin M
    Bone Miner; 1994 Nov; 27(2):159-66. PubMed ID: 7711523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interstitial collagenase activity stimulates the formation of actin rings and ruffled membranes in mouse marrow osteoclasts.
    Holliday LS; Welgus HG; Hanna J; Lee BS; Lu M; Jeffrey JJ; Gluck SL
    Calcif Tissue Int; 2003 Mar; 72(3):206-14. PubMed ID: 12522662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A rationale for osteoclast selectivity of inhibiting the lysosomal V-ATPase a3 isoform.
    Nyman JK; Väänänen HK
    Calcif Tissue Int; 2010 Sep; 87(3):273-83. PubMed ID: 20596699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imatinib mesylate (Gleevec) enhances mature osteoclast apoptosis and suppresses osteoclast bone resorbing activity.
    El Hajj Dib I; Gallet M; Mentaverri R; Sévenet N; Brazier M; Kamel S
    Eur J Pharmacol; 2006 Dec; 551(1-3):27-33. PubMed ID: 17049513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High extracellular calcium stimulates osteoclast-like cell formation and bone-resorbing activity in the presence of osteoblastic cells.
    Kaji H; Sugimoto T; Kanatani M; Chihara K
    J Bone Miner Res; 1996 Jul; 11(7):912-20. PubMed ID: 8797111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apoptosis of osteoclast-like cells induced by alendronate is related to Fas gene expression.
    Wang XM; Yu SF; Yang ZP
    Chin J Dent Res; 2000 Aug; 3(2):26-32. PubMed ID: 11314515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [3H]Bafilomycin as a probe for the transmembrane proton channel of the osteoclast vacuolar H(+)-ATPase.
    Mattsson JP; Keeling DJ
    Biochim Biophys Acta; 1996 Apr; 1280(1):98-106. PubMed ID: 8634321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nitric oxide production by the vacuolar-type (H+)-ATPase inhibitors bafilomycin A1 and concanamycin A and its possible role in apoptosis in RAW 264.7 cells.
    Hong J; Nakano Y; Yokomakura A; Ishihara K; Kim S; Kang YS; Ohuchi K
    J Pharmacol Exp Ther; 2006 Nov; 319(2):672-81. PubMed ID: 16895977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Omeprazole and bafilomycin, two proton pump inhibitors: differentiation of their effects on gastric, kidney and bone H(+)-translocating ATPases.
    Mattsson JP; Väänänen K; Wallmark B; Lorentzon P
    Biochim Biophys Acta; 1991 Jun; 1065(2):261-8. PubMed ID: 1647821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of osteoclast differentiation and function by receptor activator of NFkB ligand and osteoprotegerin.
    Shiotani A; Takami M; Itoh K; Shibasaki Y; Sasaki T
    Anat Rec; 2002 Oct; 268(2):137-46. PubMed ID: 12221720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iejimalides show anti-osteoclast activity via V-ATPase inhibition.
    Kazami S; Muroi M; Kawatani M; Kubota T; Usui T; Kobayashi J; Osada H
    Biosci Biotechnol Biochem; 2006 Jun; 70(6):1364-70. PubMed ID: 16794315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vacuolar H+-ATPase activity and expression in mouse bone marrow cultures.
    Lee BS; Holliday LS; Krits I; Gluck SL
    J Bone Miner Res; 1999 Dec; 14(12):2127-36. PubMed ID: 10620072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Bafilomycin A1: an inhibitor of vacuolar H (+)-ATPases on endocytosis and apoptosis in RAW cells and RAW cell-derived osteoclasts.
    Xu J; Feng HT; Wang C; Yip KH; Pavlos N; Papadimitriou JM; Wood D; Zheng MH
    J Cell Biochem; 2003 Apr; 88(6):1256-64. PubMed ID: 12647307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of vacuolar H(+)-ATPase in osteoclasts and its role in resorption.
    Sasaki T; Hong MH; Udagawa N; Moriyama Y
    Cell Tissue Res; 1994 Nov; 278(2):265-71. PubMed ID: 8001083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. pH dependence and inhibition by extracellular calcium of proton currents via plasmalemmal vacuolar-type H+-ATPase in murine osteoclasts.
    Sakai H; Kawawaki J; Moriura Y; Mori H; Morihata H; Kuno M
    J Physiol; 2006 Oct; 576(Pt 2):417-25. PubMed ID: 16901940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [V-ATPase inhibitor baflomycine A1 inhibits bone resorption by osteoclast-like cells].
    Zhao N; Yu S
    Zhonghua Bing Li Xue Za Zhi; 1999 Dec; 28(6):436-9. PubMed ID: 11869558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diphyllin, a novel and naturally potent V-ATPase inhibitor, abrogates acidification of the osteoclastic resorption lacunae and bone resorption.
    Sørensen MG; Henriksen K; Neutzsky-Wulff AV; Dziegiel MH; Karsdal MA
    J Bone Miner Res; 2007 Oct; 22(10):1640-8. PubMed ID: 17576165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.